Skip to main content
Fig. 7 | Journal of Hematology & Oncology

Fig. 7

From: Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Fig. 7

Flow cytometry assays to analyze the status of tumor-infiltrating natural killer cells (NKs) and dendritic cells (DCs) in the B16 model. The representative images of tumor-infiltrating a NKs, b Ki67+ NKs, c CD107a+ NKs, d TNF-α+ NKs, e Perforin+ NKs, and f DCs. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 denote the significant difference relative to combination treatment

Back to article page